A detailed history of Quent Capital, LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Quent Capital, LLC holds 200 shares of ROIV stock, worth $2,400. This represents 0.0% of its overall portfolio holdings.

Number of Shares
200
Previous 200 -0.0%
Holding current value
$2,400
Previous $2,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 08, 2024

BUY
$10.36 - $11.74 $435 - $493
42 Added 26.58%
200 $2,000
Q1 2024

May 02, 2024

BUY
$9.87 - $11.8 $1,539 - $1,840
156 Added 7800.0%
158 $1,000
Q4 2023

Jun 14, 2024

SELL
$8.38 - $11.58 $1,307 - $1,806
-156 Reduced 98.73%
2 $0
Q4 2023

Jan 19, 2024

BUY
$8.38 - $11.58 $16 - $23
2 New
2 $0

Others Institutions Holding ROIV

About Roivant Sciences Ltd.


  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $8.45B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Quent Capital, LLC Portfolio

Follow Quent Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quent Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quent Capital, LLC with notifications on news.